Epigenetic biomarkers of ageing are predictive of mortality risk in a longitudinal clinical cohort of individuals diagnosed with oropharyngeal cancer.

MLA

Beynon, Rhona A., et al. “Epigenetic Biomarkers of Ageing Are Predictive of Mortality Risk in a Longitudinal Clinical Cohort of Individuals Diagnosed with Oropharyngeal Cancer.” Clinical Epigenetics, vol. 14, no. 1, Jan. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13148-021-01220-4.

APA

Beynon, R. A., Ingle, S. M., Langdon, R., May, M., Ness, A., Martin, R. M., Suderman, M., Ingarfield, K., Marioni, R. E., McCartney, D. L., Waterboer, T., Pawlita, M., Relton, C., Smith, G. D., & Richmond, R. C. (2022). Epigenetic biomarkers of ageing are predictive of mortality risk in a longitudinal clinical cohort of individuals diagnosed with oropharyngeal cancer. Clinical Epigenetics, 14(1), 1–13. https://doi.org/10.1186/s13148-021-01220-4

Chicago

Beynon, Rhona A., Suzanne M. Ingle, Ryan Langdon, Margaret May, Andy Ness, Richard M. Martin, Matthew Suderman, et al. 2022. “Epigenetic Biomarkers of Ageing Are Predictive of Mortality Risk in a Longitudinal Clinical Cohort of Individuals Diagnosed with Oropharyngeal Cancer.” Clinical Epigenetics 14 (1): 1–13. doi:10.1186/s13148-021-01220-4.